Skip to main content
Equibles
WST logo

WST · West Pharmaceutical Services Inc · Earnings Call Transcripts & Audio

Track WST — free

Use WST with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research WST.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$370.76 -5.87 (-1.56%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$26.07B
Shares
70.38M
Volume · Sep 30 471.18K Avg daily vol (3M) 644.35K

West Pharmaceutical Services Inc Earnings Call Transcripts

Quarterly earnings calls for West Pharmaceutical Services Inc (WST), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼2.8% $686.90M $120.60M '22 Q3 22-10-27 ▼3% $708.70M $103.00M '22 Q4 23-02-16 ▼0.5% $716.60M $140.00M '23 Q1 23-04-27 ▼2.3% $753.80M $155.10M '23 Q2 23-07-27 ▲8.8% $747.40M $161.30M '23 Q3 23-10-26 ▲3.3% $732.00M $137.00M '23 Q4 24-02-15 ▼3% $695.40M $115.30M '24 Q1 24-04-25 ▼6.9% $702.10M $111.30M '24 Q2 24-07-25 ▼0.1% $746.90M $136.00M '24 Q3 24-10-24 ▲2.3% $748.80M $130.10M '24 Q4 25-02-13 ▲0.4% $698.00M $89.80M '25 Q1 25-04-24 ▲9.2% $766.50M $131.80M '25 Q2 25-07-24 ▲7.7% $804.60M $140.00M '25 Q3 25-10-23 ▲7.5% $805.00M $132.10M '25 Q4 26-02-12 ▲21% $844.90M $138.80M '26 Q1 26-04-23 LATEST ▲13.8% $872.30M $154.00M '26 Q2 26-07-23
Earnings call
FY26 · Q2
2026-07-23
West Pharmaceutical Services Inc (WST) Q2 2026 Earnings Call Transcript
Confident tone GLP-1 Demand Proprietary Products / HVP Components Growth Annex 1 / HVP Upgrade Mix Shift
Revenue
$872.30M
▲ 13.8% YoY
Diluted EPS
$2.15
▲ 18.1% YoY
Gross margin
37.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-04-23
West Pharmaceutical Services Inc (WST) Q1 2026 Earnings Call Transcript
Confident tone HVP Components / Proprietary Products GLP-1 and Orals Market Regulatory Tailwinds (Annex 1)
Revenue
$844.90M
▲ 21% YoY
Diluted EPS
$1.92
▲ 56.1% YoY
Gross margin
35.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-12
West Pharmaceutical Services Inc (WST) Q4 2025 Earnings Call Transcript
Confident tone Proprietary Products / HVP components growth GLP-1 market dynamics Capacity expansion and tech transfers
Revenue
$805.00M*
▲ 7.5% YoY
Gross margin
37.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-23
West Pharmaceutical Services Inc (WST) Q3 2025 Earnings Call Transcript
Confident tone Organic revenue growth and raised guidance Annex 1 regulatory upgrade opportunity HVP components / proprietary segment strength
Revenue
$804.60M
▲ 7.7% YoY
Diluted EPS
$1.92
▲ 3.8% YoY
Gross margin
36.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
West Pharmaceutical Services Inc (WST) Q2 2025 Earnings Call Transcript
Confident tone HVP Components and GLP-1 Growth Annex-1 Opportunity SmartDose and HVP Delivery Devices
Revenue
$766.50M
▲ 9.2% YoY
Diluted EPS
$1.82
▲ 20.5% YoY
Gross margin
35.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
West Pharmaceutical Services Inc (WST) Q1 2025 Earnings Call Transcript
Positive tone Proprietary Products / HVP components Biologics destocking and recovery Contract-manufactured products
Revenue
$698.00M
▲ 0.4% YoY
Diluted EPS
$1.23
▼ 20.6% YoY
Gross margin
33.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
West Pharmaceutical Services Inc (WST) Q4 2024 Earnings Call Transcript
Positive tone GLP-1 market growth HPP components and biologics Contract manufacturing strategy shift
Revenue
$748.80M*
▲ 2.3% YoY
Gross margin
36.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-24
West Pharmaceutical Services Inc (WST) Q3 2024 Earnings Call Transcript
Positive tone Biologics and HVP De-stocking normalization Drug delivery devices ramp
Revenue
$746.90M
▼ 0.1% YoY
Diluted EPS
$1.85
▼ 13.6% YoY
Gross margin
35.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-25
West Pharmaceutical Services Inc (WST) Q2 2024 Earnings Call Transcript
Cautious tone Proprietary Products and Biologics Customer destocking and order patterns Capacity expansion and capital projects
Revenue
$702.10M
▼ 6.9% YoY
Diluted EPS
$1.51
▼ 26.7% YoY
Gross margin
32.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript
Positive tone Customer destocking and inventory management Contract Manufacturing / GLP-1 demand HVP components and devices (Proprietary Products)
Revenue
$695.40M
▼ 3% YoY
Diluted EPS
$1.55
▼ 16.2% YoY
Gross margin
33.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
West Pharmaceutical Services Inc (WST) Q4 2023 Earnings Call Transcript
Cautious tone Capital expenditure deployment HVP (High-Value Product) capacity expansion 2024 guidance reduction and headwinds
Revenue
$732.00M*
▲ 3.3% YoY
Gross margin
38.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-26
West Pharmaceutical Services Inc (WST) Q3 2023 Earnings Call Transcript
Revenue
$747.40M
▲ 8.8% YoY
Diluted EPS
$2.14
▲ 34.6% YoY
Gross margin
38.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
West Pharmaceutical Services Inc (WST) Q2 2023 Earnings Call Transcript
Revenue
$753.80M
▼ 2.3% YoY
Diluted EPS
$2.06
▼ 16.9% YoY
Gross margin
38.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
West Pharmaceutical Services Inc (WST) Q1 2023 Earnings Call Transcript
Revenue
$716.60M
▼ 0.5% YoY
Diluted EPS
$1.85
▼ 19.2% YoY
Gross margin
37.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
West Pharmaceutical Services Inc (WST) Q4 2022 Earnings Call Transcript
Revenue
$708.70M*
▼ 3% YoY
Gross margin
37.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-27
West Pharmaceutical Services Inc (WST) Q3 2022 Earnings Call Transcript
Revenue
$686.90M
▼ 2.8% YoY
Diluted EPS
$1.59
▼ 31.2% YoY
Gross margin
39.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
West Pharmaceutical Services Inc (WST) Q2 2022 Earnings Call Transcript
Revenue
$771.30M
▲ 6.6% YoY
Diluted EPS
$2.48
▲ 0.4% YoY
Gross margin
41.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
West Pharmaceutical Services Inc (WST) Q1 2022 Earnings Call Transcript
Revenue
$720.00M
▲ 7.4% YoY
Diluted EPS
$2.29
▲ 15.1% YoY
Gross margin
39.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
West Pharmaceutical Services Inc (WST) Q4 2021 Earnings Call Transcript
Revenue
$730.80M*
▲ 26% YoY
Gross margin
41.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
West Pharmaceutical Services Inc (WST) Q3 2021 Earnings Call Transcript
Revenue
$706.50M
▲ 28.9% YoY
Diluted EPS
$2.31
▲ 111.9% YoY
Gross margin
40.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
West Pharmaceutical Services Inc (WST) Q2 2021 Earnings Call Transcript
Revenue
$723.60M
▲ 37.3% YoY
Diluted EPS
$2.47
▲ 104.1% YoY
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
West Pharmaceutical Services Inc (WST) Q1 2021 Earnings Call Transcript
Revenue
$670.70M
▲ 36.5% YoY
Diluted EPS
$1.99
▲ 101% YoY
Gross margin
40.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-18
West Pharmaceutical Services Inc (WST) Q4 2020 Earnings Call Transcript
Revenue
$580.20M
▲ 23.3% YoY
Diluted EPS
$1.29
▲ 53.6% YoY
Gross margin
36.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-22
West Pharmaceutical Services Inc (WST) Q3 2020 Earnings Call Transcript
Revenue
$548.00M
▲ 20.1% YoY
Diluted EPS
$1.09
▲ 45.3% YoY
Gross margin
35.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-23
West Pharmaceutical Services Inc (WST) Q2 2020 Earnings Call Transcript
Revenue
$527.20M
▲ 12.2% YoY
Diluted EPS
$1.21
▲ 37.5% YoY
Gross margin
37.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
West Pharmaceutical Services Inc (WST) Q1 2020 Earnings Call Transcript
Revenue
$491.50M
▲ 10.8% YoY
Diluted EPS
$0.99
▲ 35.6% YoY
Gross margin
34.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
West Pharmaceutical Services Inc (WST) Q4 2019 Earnings Call
Revenue
$470.60M
▲ 11.4% YoY
Diluted EPS
$0.84
Gross margin
32.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 105770 CUSIP 955306105 13F (30d) 19 filings 15 filers Visit website Investor relations